Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Recombinant collagenase - Connext

Drug Profile

Recombinant collagenase - Connext

Alternative Names: CNT-201; CNT-202

Latest Information Update: 19 Aug 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Connext
  • Class Collagenases; Recombinant proteins; Skin disorder therapies
  • Mechanism of Action Collagenase replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes - Cellulite; Dupuytren's contracture; Peyronie's disease; Wounds

Highest Development Phases

  • Phase I/II Dupuytren's contracture
  • Phase I Cellulite; Peyronie's disease
  • Preclinical Wounds

Most Recent Events

  • 17 Aug 2026 Recombinant collagenase is still in preclinical phase for Wounds in South Korea (Parenteral) (Connext pipeline; August 2026)
  • 17 Aug 2026 Phase-I clinical trials in Cellulite (Parenteral) prior to August 2026 (Connext pipeline, August 2026)
  • 17 Aug 2026 Phase-I clinical trials in Peyronie's disease (Parenteral) prior to August 2026 (Connext pipeline, August 2026)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top